SOX as Salvage Treatment in Nasopharyngeal Carcinoma
NCT01403259
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
16
Enrollment
OTHER
Sponsor class
Stopped
poor accrual of eligible patients
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
S-1 plus oxaliplatin
Sponsor
Fudan University